Fixed-dose combination
Sofosbuvir, Velpatasvir and Voxilaprevi
- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Sofosbuvir, Velpatasvir and Voxilaprevi is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- J05A Direct acting antiviral · Antivirals for systemic use
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Fixed-dose combination of
- Sofosbuvir, Velpatasvir, Voxilaprevi
All presentations
No presentations of Sofosbuvir, Velpatasvir and Voxilaprevi are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Sofosbuvir, Velpatasvir and Voxilaprevi available for export from India?
No presentation of Sofosbuvir, Velpatasvir and Voxilaprevi is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Sofosbuvir, Velpatasvir and Voxilaprevi authorised in the European Union?
Yes. Sofosbuvir, Velpatasvir and Voxilaprevi has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Sofosbuvir, Velpatasvir and Voxilaprevi need cold chain shipping?
No listed presentation of Sofosbuvir, Velpatasvir and Voxilaprevi is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Sofosbuvir, Velpatasvir and Voxilaprevi in?
Sofosbuvir, Velpatasvir and Voxilaprevi is classified under ATC code J05A (Direct acting antiviral).
References
- Vosevi: European public assessment report (EPAR). European Medicines Agency. Retrieved 27 September 2023
Request Sofosbuvir, Velpatasvir and Voxilaprevi for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.